![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
Tools
Tools
Preview |
PDF (Original Article)
- Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
8MB |
![[thumbnail of Supplementary Data]](https://edoc.mdc-berlin.de/style/images/fileicons/other.png) |
Other (Supplementary Data)
25MB |
| Item Type: | Article |
|---|---|
| Title: | Targeting PRMT5 inhibitor-induced adaptation in pancreatic cancer with the RBM39 degrader indisulam |
| Creators: |
Spielmann, Valentina  ORCID: https://orcid.org/0009-0004-7138-4360, Buchloh, Jonas ORCID: https://orcid.org/0000-0002-9820-3054, Selcen, Selen ORCID: https://orcid.org/0009-0006-4006-4369, Schneider, Carolin ORCID: https://orcid.org/0000-0003-3539-9026, Jansari, Shaishavi ORCID: https://orcid.org/0009-0002-0495-3012, Fang, Xin ORCID: https://orcid.org/0000-0003-2098-6623, Duan, Ningjun ORCID: https://orcid.org/0000-0001-6316-3796, Demirdizen, Engin ORCID: https://orcid.org/0009-0004-9346-7458, Krauß, Lukas ORCID: https://orcid.org/0000-0003-0062-8685, Eggert, Jessica ORCID: https://orcid.org/0009-0006-1588-6205, Siegfried, Geraldine ORCID: https://orcid.org/0000-0002-6346-5206, Fedou, Sandrine ORCID: https://orcid.org/0000-0003-3952-607X, Lenz, Christof ORCID: https://orcid.org/0000-0002-0946-8166, Wieland, Lena ORCID: https://orcid.org/0009-0006-5969-1012, Conradi, Lena-Christin ORCID: https://orcid.org/0000-0002-9488-1018, Reichert, Maximilian ORCID: https://orcid.org/0000-0002-8611-5639, Ellenrieder, Volker ORCID: https://orcid.org/0000-0001-9981-8571, Ghadimi, Michael ORCID: https://orcid.org/0000-0001-8208-1526, Grade, Marian ORCID: https://orcid.org/0000-0001-9527-5362, Hessmann, Elisabeth ORCID: https://orcid.org/0000-0002-9462-1291, Khatib, Abdel-Majid ORCID: https://orcid.org/0000-0001-6957-0384, Braun, Christian J. ORCID: https://orcid.org/0000-0003-1704-6219, Wegwitz, Florian ORCID: https://orcid.org/0000-0003-0750-6998, Saur, Dieter ORCID: https://orcid.org/0000-0001-5874-0210, Wirth, Matthias ORCID: https://orcid.org/0000-0002-8340-0872 and Schneider, Günter ORCID: https://orcid.org/0000-0003-1840-4508
|
| Abstract: | Pancreatic ductal adenocarcinoma (PDAC) remains a formidable clinical challenge. Next-generation protein arginine methyltransferase 5 (PRMT5) inhibitors show promising clinical results in a subset of PDACs with codeletion of the tumor-suppressor CDKN2A and the methylthioadenosine phosphorylase (MTAP) gene, but resistance limits their efficacy. Our study suggests that compensatory spliceosomal reprogramming contributes to adaptation to PRMT5 inhibition. Through comprehensive molecular profiling, we demonstrate that PRMT5 inhibitors induce upregulation of RNA-binding proteins, including RNA-binding protein 39 (RBM39). We investigated whether this response could be therapeutically leveraged by combining PRMT5 inhibition with indisulam-mediated RBM39 degradation, which yielded synergistic activity in cellular model systems. The combination strategy significantly enhanced apoptotic cell death and suppressed tumor outgrowth in resistance assays compared with single-agent treatments. Multiomics analysis revealed concomitant suppression of DNA repair and metabolic pathways. Collectively, our work support spliceosomal rewiring as a candidate adaptive response to PRMT5 inhibition and nominates RBM39 as a candidate therapeutic vulnerability, thereby supporting further evaluation of dual targeting of the splicing machinery. SIGNIFICANCE: Our study suggests that compensatory spliceosomal reprogramming occurs in response to PRMT5 inhibition. We investigated this vulnerability by combining PRMT5 inhibition with indisulam-mediated RBM39 degradation, which yielded synergistic antitumor activity in selected cellular PDAC models. |
| Keywords: | Apoptosis, Neoplastic Gene Expression Regulation, Pancreatic Ductal Carcinoma, Pancreatic Neoplasms, Protein-Arginine N-Methyltransferases, RNA-Binding Proteins, Spliceosomes, Tumor Cell Line, Xenograft Model Antitumor Assays, Animals, Mice |
| Source: | Cancer Research Communications |
| ISSN: | 2767-9764 |
| Publisher: | American Association for Cancer Research |
| Volume: | 6 |
| Number: | 9 |
| Page Range: | 2039-2055 |
| Date: | 1 September 2026 |
| Official Publication: | https://doi.org/10.1158/2767-9764.crc-25-0670 |
| PubMed: | View item in PubMed |
| Related to: |
Repository Staff Only: item control page
